Sucampo Pharmaceuticals

Investments

1

Lead Investments

1

Sucampo Pharmaceuticals, Inc. was a pharmaceutical company focused on the development and commercialization of specialized medicines, particularly in the fields of gastroenterology, ophthalmology, and oncology. The company was acquired by Mallinckrodt in 2018.

Founded 1996

North America, United States

51-100

www2.mallinckrodt.com